JYP-0061

N/A

Report date: 2025/09/24 15:05:20
NME

Base Information

Drug NameJYP-0061
Drug Alias NameJYP-0061
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsPrurigo NodularisAutoimmune DiseasesVitiligo +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Jiayue Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Jiayue Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisAutoimmune DiseasesVitiligo +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A